DE602004025050D1 - Spinosyne für die wundheilung - Google Patents

Spinosyne für die wundheilung

Info

Publication number
DE602004025050D1
DE602004025050D1 DE602004025050T DE602004025050T DE602004025050D1 DE 602004025050 D1 DE602004025050 D1 DE 602004025050D1 DE 602004025050 T DE602004025050 T DE 602004025050T DE 602004025050 T DE602004025050 T DE 602004025050T DE 602004025050 D1 DE602004025050 D1 DE 602004025050D1
Authority
DE
Germany
Prior art keywords
wound healing
spinosyne
spinosyn
humans
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004025050T
Other languages
English (en)
Inventor
Kristina Clare Hacket
Lionel Barry Lowe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE602004025050D1 publication Critical patent/DE602004025050D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE602004025050T 2004-04-29 2004-04-29 Spinosyne für die wundheilung Expired - Lifetime DE602004025050D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/011268 WO2005112950A1 (en) 2004-04-29 2004-04-29 Spinosyns for wound healing

Publications (1)

Publication Number Publication Date
DE602004025050D1 true DE602004025050D1 (de) 2010-02-25

Family

ID=34957480

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004025050T Expired - Lifetime DE602004025050D1 (de) 2004-04-29 2004-04-29 Spinosyne für die wundheilung

Country Status (22)

Country Link
US (2) US7709447B2 (de)
EP (1) EP1744763B1 (de)
JP (1) JP4880589B2 (de)
CN (1) CN1942194B (de)
AT (1) ATE454156T1 (de)
AU (1) AU2004319804B2 (de)
BR (1) BRPI0418764B8 (de)
CA (1) CA2563800C (de)
CY (1) CY1109840T1 (de)
DE (1) DE602004025050D1 (de)
DK (1) DK1744763T3 (de)
EA (1) EA010975B1 (de)
ES (1) ES2336573T3 (de)
HK (1) HK1099519A1 (de)
HR (1) HRP20100137T1 (de)
IL (1) IL178399A (de)
MX (1) MXPA06012388A (de)
NO (1) NO337210B1 (de)
PL (1) PL1744763T3 (de)
PT (1) PT1744763E (de)
SI (1) SI1744763T1 (de)
WO (1) WO2005112950A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0603252D0 (en) 2006-02-17 2006-03-29 Axcess Ltd Dissolution aids for oral peptide delivery
EP2653160B1 (de) 2006-10-12 2017-09-27 Topaz Pharmaceuticals Inc. Topische Ivermectin-Formulierungen und Verfahren zur Verhinderung und Prophylaxe von Körperläusen
US8697661B2 (en) 2009-06-24 2014-04-15 Christine Kritikou Use of spinosyns and spinosyn compositions against herpesviridae viral infections
US9474729B2 (en) * 2010-01-14 2016-10-25 Hydromer, Inc. Topical antimicrobial compositions and methods of using same
US9918991B2 (en) * 2010-01-14 2018-03-20 Hydromer, Inc. Topical antimicrobial compositions and methods of using same
JP2013518045A (ja) 2010-01-25 2013-05-20 イーライ リリー アンド カンパニー ウマ科のウマバエの幼虫を内部抑制または処置する方法
US10279007B2 (en) 2010-11-15 2019-05-07 Oxygenetix Institute, Inc. Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
US20160184340A1 (en) * 2010-12-22 2016-06-30 Christine Kritikou The use of spinosyns and spinosyn compositions as local anesthetics and as antiarrhythmic agents
MX2018002538A (es) 2015-09-03 2018-08-14 Agrimetis Llc Derivados de espinosina.
EP3568399A1 (de) 2017-01-13 2019-11-20 Agrimetis, LLC Aziridin-spinosyn-derivate und verfahren zur herstellung
JP2021532152A (ja) 2018-07-27 2021-11-25 アペルタ バイオサイエンシズ，エルエルシー デモデックスにより誘発される眼の異常および顔面の異常を治療するためのスピノシン配合

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122011100022I1 (de) * 1999-08-12 2011-10-20 Lilly Co Eli Verwendung von Spinosad oder einer Zusammensetzungenthaltend spinosad.
WO2001011961A1 (en) * 1999-08-12 2001-02-22 Eli Lilly And Company Control of ectoparasites using spinosyns
US6727228B2 (en) 2001-04-25 2004-04-27 Johnson & Johnson Consumer Companies, Inc. Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
US20030026848A1 (en) * 2001-07-06 2003-02-06 Joshi Ashok V. Beneficial materials for topical or internal use by a human or other animal
KR20040045440A (ko) * 2001-09-17 2004-06-01 일라이 릴리 앤드 캄파니 농약 배합물

Also Published As

Publication number Publication date
BRPI0418764A (pt) 2007-07-24
CA2563800A1 (en) 2005-12-01
AU2004319804B2 (en) 2010-08-05
US20070167379A1 (en) 2007-07-19
EA010975B1 (ru) 2008-12-30
CN1942194A (zh) 2007-04-04
US7709447B2 (en) 2010-05-04
EA200602002A1 (ru) 2007-02-27
CA2563800C (en) 2011-06-28
ES2336573T3 (es) 2010-04-14
EP1744763B1 (de) 2010-01-06
NO337210B1 (no) 2016-02-08
BRPI0418764B8 (pt) 2021-07-27
PL1744763T3 (pl) 2010-06-30
BRPI0418764B1 (pt) 2019-01-22
AU2004319804A1 (en) 2005-12-01
HRP20100137T1 (hr) 2010-04-30
IL178399A (en) 2011-03-31
JP2007534750A (ja) 2007-11-29
JP4880589B2 (ja) 2012-02-22
SI1744763T1 (sl) 2010-05-31
DK1744763T3 (da) 2010-03-22
HK1099519A1 (en) 2007-08-17
ATE454156T1 (de) 2010-01-15
MXPA06012388A (es) 2007-01-17
IL178399A0 (en) 2008-04-13
CY1109840T1 (el) 2014-09-10
WO2005112950A1 (en) 2005-12-01
US20100173857A1 (en) 2010-07-08
CN1942194B (zh) 2010-05-26
EP1744763A1 (de) 2007-01-24
NO20065447L (no) 2006-11-27
PT1744763E (pt) 2010-03-31
US8536142B2 (en) 2013-09-17

Similar Documents

Publication Publication Date Title
HK1099519A1 (en) Spinosyns for wound healing
NO2019033I1 (no) regorafenib
NO20080333L (no) Sårheling
DE602004022375D1 (de) Verteiltes Echtzeitbetriebssystem
NL1031626A1 (nl) Verbindingen die bruikbaar zijn in therapie.
DE602006019915D1 (de) Isoxazoline für die bekämpfung von wirbellosen schädlingen
DE50307231D1 (de) Implantat für Osteosynthese
ATE488995T1 (de) Fungizide wässrige zusammensetzungen für die saatgutbehandlung
DE502005008185D1 (de) Applikator für die wasserstrahl-chirurgie
ATE527355T1 (de) Halbweiche immunstimulierende oligonukleotide der c-klasse
ATE408664T1 (de) Abgabesystem für wirkstoff
EP1965818A4 (de) Wundheilungsverfahren
IS8147A (is) Nýjar línkómýsín afleiður sem búa yfir örverueyðandi virkni
DE60331055D1 (de) Retraktor für organe
ME01459B (me) Postupak za doziranje medikamenata
DE602004000756D1 (de) Doppelköderstation für insekten
ATE372674T1 (de) N-arylhydrazonderivate für die saatgutbehandlung
DE602006007631D1 (de) Verpackung für implantierbare chirurgische Netze.
PT1556377E (pt) Ciclopropil-tienil-carboxamidas como fungicidas
PT1381609E (pt) 5-halogeno-6-fenil-7-fluoroalquilamino-triazolopirimidinas como fungicidas
DE60328419D1 (de) Set für die augenchirurgie
ATE414107T1 (de) Zusammensetzung für die gewebepflege
ATE444675T1 (de) Steuerbarer, beweglicher zaun für vieh
EP1804817A4 (de) Verfahren zur förderung der wundheilung
SG159395A1 (en) Use of spinosyns for wound healing

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN